Proactive management strategies for potential gastrointestinal adverse reactions with ceritinib in patients with advanced ALK-positive non-small-cell lung cancer

por Schaefer, Eric S, Baik, Christina
Publicado 2016

Symptom Management Strategies for Patients Receiving Anaplastic Lymphoma Kinase Inhibitors for Non–Small Cell Lung Cancer

por Jacky, Jennifer, Baik, Christina
Publicado 2017

Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy

por Baik, Christina S., Eaton, Keith D.
Publicado 2012

Durable Response of Leptomeningeal Disease With Osimertinib and Pemetrexed in EGFR-Mutated Metastatic NSCLC: A Case Report

por Merkhofer, Cristina M., Baik, Christina S.
Publicado 2021

Targeting BRAF‐Mutant Non‐Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy

por Baik, Christina S., Myall, Nathaniel J., Wakelee, Heather A.
Publicado 2017

HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies

por Uy, Natalie F., Merkhofer, Cristina M., Baik, Christina S.
Publicado 2022

58. CLINICAL PRESENTATION AND IMAGING CHARACTERISTICS OF LEPTOMENINGEAL CARCINOMATOSIS (LC) IN PATIENTS WITH EGFR MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)

por Eastman, Boryana, Merkhofer, Cristina, Densmore, Isabella, Baik, Christina, Halasz, Lia, McGranahan, Tresa
Publicado 2020

A qualitative study of interactions with oncologists among patients with advanced lung cancer

por Al Achkar, Morhaf, Basu Roy, Upal, Manley, Eugene, Standifer, Maisha, Baik, Christina, Walsh, Casey A.
Publicado 2022

Outcomes Among Homeless Patients With Non–Small-Cell Lung Cancer: A County Hospital Experience

por Concannon, Kyle F., Thayer, John H., Wu, Qian V., Jenkins, Isaac C., Baik, Christina S., Linden, Hannah M.
Publicado 2020

Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With BRAF-Mutated Advanced NSCLC

por Johnson, Bruce E., Baik, Christina S., Mazieres, Julien, Groen, Harry J.M., Melosky, Barbara, Wolf, Jürgen, Zadeh Vosta Kolaei, Fatemeh Asad, Wu, Wen-Hsing, Knoll, Stefanie, Ktiouet Dawson, Meryem, Johns, Adam, Planchard, David
Publicado 2022

Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients

por Chalker, Cameron, Voutsinas, Jenna M., Wu, Qian Vicky, Santana‐Davila, Rafael, Hwang, Victoria, Baik, Christina S., Lee, Sylvia, Barber, Brittany, Futran, Neal D., Houlton, Jeffrey J., Laramore, George E., Liao, Jay Justin, Parvathaneni, Upendra, Martins, Renato G., Eaton, Keith D., Rodriguez, Cristina P.
Publicado 2022

Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chem...

por Bowen, Stephen R., Hippe, Daniel S., Thomas, Hannah M., Sasidharan, Balukrishna, Lampe, Paul D., Baik, Christina S., Eaton, Keith D., Lee, Sylvia, Martins, Renato G., Santana-Davila, Rafael, Chen, Delphine L., Kinahan, Paul E., Miyaoka, Robert S., Vesselle, Hubert J., Houghton, A. McGarry, Rengan, Ramesh, Zeng, Jing
Publicado 2021

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer

por Jänne, Pasi A., Baik, Christina, Su, Wu-Chou, Johnson, Melissa L., Hayashi, Hidetoshi, Nishio, Makoto, Kim, Dong-Wan, Koczywas, Marianna, Gold, Kathryn A., Steuer, Conor E., Murakami, Haruyasu, Yang, James Chih-Hsin, Kim, Sang-We, Vigliotti, Michele, Shi, Rong, Qi, Zhenhao, Qiu, Yang, Zhao, Lihui, Sternberg, David, Yu, Channing, Yu, Helena A.
Publicado 2022